The Pandemic’s Effect on the Widening Gap in Mortality Rate between the U.S. and Peer Countries

The Pandemic’s Effect on the Widening Gap in Mortality Rate between the U.S. and Peer Countries

A new KFF brief looks at where COVID-19 falls as a leading cause of death in the U.S. compared to similarly large and wealthy countries. The analysis finds that COVID-19 mortality rates are the third leading cause of death in

Read More The Pandemic’s Effect on the Widening Gap in Mortality Rate between the U.S. and Peer Countries

Doctor on Demand strikes partnership with home care company CareLinx

Doctor on Demand strikes partnership with home care company CareLinx

Doctor On Demand struck a partnership with in-home care company CareLinx, to offer  telehealth services to seniors that use CareLinx’s services. Photo credit: Doctor on Demand In May, after seeing a significant number of seniors turn to virtual care during

Read More Doctor on Demand strikes partnership with home care company CareLinx

Medicaid enrollment boost wouldn’t offset lower utilization, payer mix changes

Medicaid enrollment boost wouldn't offset lower utilization, payer mix changes

Safety-net providers could get some financial relief from an uptick in Medicaid enrollment early next year, but it probably won’t be enough to offset declines in healthcare utilization or changes to payer mix.When the COVID-19 pandemic began, many experts predicted

Read More Medicaid enrollment boost wouldn’t offset lower utilization, payer mix changes

CareLinx, Doctor On Demand Team Up to Provide Virtual Care at Home

Amedisys Floats Future Innovation Plans, Details COVID-19 Costs

CareLinx is teaming up with virtual primary care provider Doctor On Demand to give high-risk seniors access to services in their homes.  Burlingame, California-based CareLinx is a tech-enabled home care platform that connects seniors and their families to its nationwide

Read More CareLinx, Doctor On Demand Team Up to Provide Virtual Care at Home

Envision, Cigna avert out-of-network status in Florida

Envision, Cigna avert out-of-network status in Florida

Dive Brief: Private-equity backed Envision Healthcare and Cigna have reached a deal to retain the physician services group in the insurer’s network in Florida.  Envision has a network of more than 6,000 clinicians including anesthesia, emergency medicine, radiology, neonatology, surgical

Read More Envision, Cigna avert out-of-network status in Florida

Analysis: COVID-19 Ranks as a Top 3 Leading Cause of Death in the U.S., Higher than in Almost All Other Peer Countries

Abortion at SCOTUS: Potential Cases this Term and Possible Rulings

A new KFF analysis examines leading causes of death and mortality rates in the United States and comparable countries. The U.S. has a higher COVID-19 mortality rate than many of its peer countries, with COVID-19 ranking as the nation’s third-leading

Read More Analysis: COVID-19 Ranks as a Top 3 Leading Cause of Death in the U.S., Higher than in Almost All Other Peer Countries

Biden’s Big Health Agenda Won’t Be Easy to Achieve

Biden’s Big Health Agenda Won’t Be Easy to Achieve

If Joe Biden wins the presidency in November, health is likely to play a high-profile role in his agenda. Just probably not in the way he or anyone else might have predicted. Barring something truly unforeseen, it’s fairly certain that

Read More Biden’s Big Health Agenda Won’t Be Easy to Achieve

Landmark FDA approval of antiviral drug as 1st COVID-19 treatment comes amid conflicting efficacy data

Red seal and imprint "FDA APPROVED" on white surface. FDA - Food and Drug Administration is a federal agency of the United States Department of Health and Human Services.

The FDA has approved remdesivir for the treatment of Covid-19, making it the first and only treatment for the disease caused by the new coronavirus. The green light from the agency comes just one week after a WHO report found

Read More Landmark FDA approval of antiviral drug as 1st COVID-19 treatment comes amid conflicting efficacy data

FDA approves first COVID-19 drug: antiviral remdesivir

COVID-19 patients have same viral load regardless of symptom severity

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days

Read More FDA approves first COVID-19 drug: antiviral remdesivir

Right at Home Partners with Home Modification Company TruBlue to Expand Aging-in-Place Services

Right at Home Partners with Home Modification Company TruBlue to Expand Aging-in-Place Services

Home-based care companies are trying to become one-stop shops for seniors wishing to age in place. That’s why, when Omaha, Nebraska-based Right at Home’s executives saw a Home Health Care News article highlighting home modification franchise TruBlue Total House Care,

Read More Right at Home Partners with Home Modification Company TruBlue to Expand Aging-in-Place Services